Global Kyphoplasty Market

Kyphoplasty Comprehensive Study by Type (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems, Instruments), Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis), End-users (Hospitals, Clinics, Ambulatory Surgical Devices, Others), Indication (Osteoporosis, Others) Players and Region - Global Market Outlook to 2027

Kyphoplasty Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Kyphoplasty?
Kyphoplasty is the standard surgical treatment for vertebral compression fractures. The goal of this study was to determine the effect of kyphoplasty on the sagittal profile as well as the relationship between posture improvement and pain relief. We assessed various sagittal profile radiological parameters on whole spine standing radiographs of 73 patients with a single vertebral fracture treated with kyphoplasty for this purpose. The main result was a postoperative change in the sagittal vertical axis (SVA). In addition, clinical parameters such as pain scores on a visual analogue scale (VAS) and analgesic use were obtained from medical records. Preoperative and postoperative radiological and clinical parameters were compared. Additionally, the relationship between changes in SVA and changes in local kyphotic angle (LKA) or VAS was investigated. Clinical and radiographic parameters (SVA, LKA, Gardner, and Cobb) improved significantly postoperatively.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledStryker (United States), Medtronic Inc. (Ireland), Smith & Nephew (United Kingdom), MicroPort Scientific Corporation (China), DePuy Synthes (United States), IZI Medical Products (United States), CareFusion (United States), Merit Medical Systems (United States), joimax GmbH (United States) and G21 S.r.l. (Italy)


The study covers a detailed analysis segmented by key business segments i.e. by type (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems and Instruments) , by application (Vertebral Alignment Restoration, Spinal Fractures and Kyphosis) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Kyphoplasty market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Kyphoplasty market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Stryker (United States), Medtronic Inc. (Ireland), Smith & Nephew (United Kingdom), MicroPort Scientific Corporation (China), DePuy Synthes (United States), IZI Medical Products (United States), CareFusion (United States), Merit Medical Systems (United States), joimax GmbH (United States) and G21 S.r.l. (Italy).

Market Overview:
On 23rd February 2022, Stryker announced that the previously announced acquisition of Vocera Communications, Inc., a leader in digital care coordination and communication, has been completed. According to Kevin Lobo, Chair and Chief Executive Officer of Stryker, this acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations. We welcome the Vocera team to Stryker and look forward to collaborating to provide safer patient care and assist our customers in improving outcomes. Stryker's Medical division brings to Vocera a highly complementary and innovative portfolio that will enhance the company's Advanced Digital Healthcare offerings and advance Stryker's focus on preventing adverse events throughout the continuum of care.
Before the enactment of the FDA's device regulation, polymethyl methacrylate (PMMA) bone cement was available as a drug product and was initially classified as a transitional device. It was upgraded to a class III device, requiring premarket applications. Several orthopedic companies have received approval for their bone cement products to be used for purposes other than vertebroplasty or kyphoplasty. PMMA was reclassified from class III to class II, requiring future 510(k) submissions to meet special controls rather than general controls to ensure safety and effectiveness.
As preferred strategies, the companies are exploring the market through expansions, investments, new service launches, and collaborations. To gain a competitive advantage through collaborative efforts, the players are expanding and acquiring new geographies around the world.

Kyphoplasty Market Dynamics:
AttributesDetails
Growth Drivers
  • Increased Prevalence of Kyphoplasty Compression Fractures
  • Increased Number of Diagnostic Centers and Hospitals
Major Trends
  • Rise in the Healthcare Infrastructure in Developing Regions
  • Advancements in Image-guided Surgical Procedures
Restraints
  • Less of Awareness among Patients
Road Blocks / Challenges
  • Stringent Government Rules and Regulations
Gaps & Opportunities
  • Growing Geriatric Population Worldwide
  • Growth in the Healthcare Industry
  • Increasing Research and Development Activities


Key highlights of the Global Kyphoplasty market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Kyphoplasty market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Kyphoplasty market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Kyphoplasty Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Kyphoplasty market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Kyphoplasty market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, New Entrants and Investors, Small and large enterprises, Research & consultants, Kyphoplasty Device Manufacturers, Emerging Companies, Research Professionals, Government Bodies, End-Users and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Balloon Catheters
  • Bone Access Devices
  • Cement Application Products
  • Bone Cement
  • Cement Mixing Systems
  • Instruments
By Application
  • Vertebral Alignment Restoration
  • Spinal Fractures
  • Kyphosis
By End-users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Devices
  • Others

By Indication
  • Osteoporosis
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Kyphoplasty Compression Fractures
      • 3.2.2. Increased Number of Diagnostic Centers and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Rise in the Healthcare Infrastructure in Developing Regions
      • 3.4.2. Advancements in Image-guided Surgical Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Kyphoplasty, by Type, Application, End-users, Indication and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Kyphoplasty (Value)
      • 5.2.1. Global Kyphoplasty by: Type (Value)
        • 5.2.1.1. Balloon Catheters
        • 5.2.1.2. Bone Access Devices
        • 5.2.1.3. Cement Application Products
        • 5.2.1.4. Bone Cement
        • 5.2.1.5. Cement Mixing Systems
        • 5.2.1.6. Instruments
      • 5.2.2. Global Kyphoplasty by: Application (Value)
        • 5.2.2.1. Vertebral Alignment Restoration
        • 5.2.2.2. Spinal Fractures
        • 5.2.2.3. Kyphosis
      • 5.2.3. Global Kyphoplasty by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory Surgical Devices
        • 5.2.3.4. Others
      • 5.2.4. Global Kyphoplasty by: Indication (Value)
        • 5.2.4.1. Osteoporosis
        • 5.2.4.2. Others
      • 5.2.5. Global Kyphoplasty Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Kyphoplasty: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic Inc. (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Smith & Nephew (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MicroPort Scientific Corporation (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DePuy Synthes (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. IZI Medical Products (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CareFusion (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merit Medical Systems (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Joimax GmbH (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. G21 S.r.l. (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Kyphoplasty Sale, by Type, Application, End-users, Indication and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Kyphoplasty (Value)
      • 7.2.1. Global Kyphoplasty by: Type (Value)
        • 7.2.1.1. Balloon Catheters
        • 7.2.1.2. Bone Access Devices
        • 7.2.1.3. Cement Application Products
        • 7.2.1.4. Bone Cement
        • 7.2.1.5. Cement Mixing Systems
        • 7.2.1.6. Instruments
      • 7.2.2. Global Kyphoplasty by: Application (Value)
        • 7.2.2.1. Vertebral Alignment Restoration
        • 7.2.2.2. Spinal Fractures
        • 7.2.2.3. Kyphosis
      • 7.2.3. Global Kyphoplasty by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory Surgical Devices
        • 7.2.3.4. Others
      • 7.2.4. Global Kyphoplasty by: Indication (Value)
        • 7.2.4.1. Osteoporosis
        • 7.2.4.2. Others
      • 7.2.5. Global Kyphoplasty Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Kyphoplasty: by Type(USD Million)
  • Table 2. Kyphoplasty Balloon Catheters , by Region USD Million (2016-2021)
  • Table 3. Kyphoplasty Bone Access Devices , by Region USD Million (2016-2021)
  • Table 4. Kyphoplasty Cement Application Products , by Region USD Million (2016-2021)
  • Table 5. Kyphoplasty Bone Cement , by Region USD Million (2016-2021)
  • Table 6. Kyphoplasty Cement Mixing Systems , by Region USD Million (2016-2021)
  • Table 7. Kyphoplasty Instruments , by Region USD Million (2016-2021)
  • Table 8. Kyphoplasty: by Application(USD Million)
  • Table 9. Kyphoplasty Vertebral Alignment Restoration , by Region USD Million (2016-2021)
  • Table 10. Kyphoplasty Spinal Fractures , by Region USD Million (2016-2021)
  • Table 11. Kyphoplasty Kyphosis , by Region USD Million (2016-2021)
  • Table 12. Kyphoplasty: by End-users(USD Million)
  • Table 13. Kyphoplasty Hospitals , by Region USD Million (2016-2021)
  • Table 14. Kyphoplasty Clinics , by Region USD Million (2016-2021)
  • Table 15. Kyphoplasty Ambulatory Surgical Devices , by Region USD Million (2016-2021)
  • Table 16. Kyphoplasty Others , by Region USD Million (2016-2021)
  • Table 17. Kyphoplasty: by Indication(USD Million)
  • Table 18. Kyphoplasty Osteoporosis , by Region USD Million (2016-2021)
  • Table 19. Kyphoplasty Others , by Region USD Million (2016-2021)
  • Table 20. South America Kyphoplasty, by Country USD Million (2016-2021)
  • Table 21. South America Kyphoplasty, by Type USD Million (2016-2021)
  • Table 22. South America Kyphoplasty, by Application USD Million (2016-2021)
  • Table 23. South America Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 24. South America Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 25. Brazil Kyphoplasty, by Type USD Million (2016-2021)
  • Table 26. Brazil Kyphoplasty, by Application USD Million (2016-2021)
  • Table 27. Brazil Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 28. Brazil Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 29. Argentina Kyphoplasty, by Type USD Million (2016-2021)
  • Table 30. Argentina Kyphoplasty, by Application USD Million (2016-2021)
  • Table 31. Argentina Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 32. Argentina Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 33. Rest of South America Kyphoplasty, by Type USD Million (2016-2021)
  • Table 34. Rest of South America Kyphoplasty, by Application USD Million (2016-2021)
  • Table 35. Rest of South America Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 36. Rest of South America Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 37. Asia Pacific Kyphoplasty, by Country USD Million (2016-2021)
  • Table 38. Asia Pacific Kyphoplasty, by Type USD Million (2016-2021)
  • Table 39. Asia Pacific Kyphoplasty, by Application USD Million (2016-2021)
  • Table 40. Asia Pacific Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 41. Asia Pacific Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 42. China Kyphoplasty, by Type USD Million (2016-2021)
  • Table 43. China Kyphoplasty, by Application USD Million (2016-2021)
  • Table 44. China Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 45. China Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 46. Japan Kyphoplasty, by Type USD Million (2016-2021)
  • Table 47. Japan Kyphoplasty, by Application USD Million (2016-2021)
  • Table 48. Japan Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 49. Japan Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 50. India Kyphoplasty, by Type USD Million (2016-2021)
  • Table 51. India Kyphoplasty, by Application USD Million (2016-2021)
  • Table 52. India Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 53. India Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 54. South Korea Kyphoplasty, by Type USD Million (2016-2021)
  • Table 55. South Korea Kyphoplasty, by Application USD Million (2016-2021)
  • Table 56. South Korea Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 57. South Korea Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 58. Australia Kyphoplasty, by Type USD Million (2016-2021)
  • Table 59. Australia Kyphoplasty, by Application USD Million (2016-2021)
  • Table 60. Australia Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 61. Australia Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Kyphoplasty, by Type USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Kyphoplasty, by Application USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 66. Europe Kyphoplasty, by Country USD Million (2016-2021)
  • Table 67. Europe Kyphoplasty, by Type USD Million (2016-2021)
  • Table 68. Europe Kyphoplasty, by Application USD Million (2016-2021)
  • Table 69. Europe Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 70. Europe Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 71. Germany Kyphoplasty, by Type USD Million (2016-2021)
  • Table 72. Germany Kyphoplasty, by Application USD Million (2016-2021)
  • Table 73. Germany Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 74. Germany Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 75. France Kyphoplasty, by Type USD Million (2016-2021)
  • Table 76. France Kyphoplasty, by Application USD Million (2016-2021)
  • Table 77. France Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 78. France Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 79. Italy Kyphoplasty, by Type USD Million (2016-2021)
  • Table 80. Italy Kyphoplasty, by Application USD Million (2016-2021)
  • Table 81. Italy Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 82. Italy Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 83. United Kingdom Kyphoplasty, by Type USD Million (2016-2021)
  • Table 84. United Kingdom Kyphoplasty, by Application USD Million (2016-2021)
  • Table 85. United Kingdom Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 86. United Kingdom Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 87. Netherlands Kyphoplasty, by Type USD Million (2016-2021)
  • Table 88. Netherlands Kyphoplasty, by Application USD Million (2016-2021)
  • Table 89. Netherlands Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 90. Netherlands Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 91. Rest of Europe Kyphoplasty, by Type USD Million (2016-2021)
  • Table 92. Rest of Europe Kyphoplasty, by Application USD Million (2016-2021)
  • Table 93. Rest of Europe Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 94. Rest of Europe Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 95. MEA Kyphoplasty, by Country USD Million (2016-2021)
  • Table 96. MEA Kyphoplasty, by Type USD Million (2016-2021)
  • Table 97. MEA Kyphoplasty, by Application USD Million (2016-2021)
  • Table 98. MEA Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 99. MEA Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 100. Middle East Kyphoplasty, by Type USD Million (2016-2021)
  • Table 101. Middle East Kyphoplasty, by Application USD Million (2016-2021)
  • Table 102. Middle East Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 103. Middle East Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 104. Africa Kyphoplasty, by Type USD Million (2016-2021)
  • Table 105. Africa Kyphoplasty, by Application USD Million (2016-2021)
  • Table 106. Africa Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 107. Africa Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 108. North America Kyphoplasty, by Country USD Million (2016-2021)
  • Table 109. North America Kyphoplasty, by Type USD Million (2016-2021)
  • Table 110. North America Kyphoplasty, by Application USD Million (2016-2021)
  • Table 111. North America Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 112. North America Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 113. United States Kyphoplasty, by Type USD Million (2016-2021)
  • Table 114. United States Kyphoplasty, by Application USD Million (2016-2021)
  • Table 115. United States Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 116. United States Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 117. Canada Kyphoplasty, by Type USD Million (2016-2021)
  • Table 118. Canada Kyphoplasty, by Application USD Million (2016-2021)
  • Table 119. Canada Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 120. Canada Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 121. Mexico Kyphoplasty, by Type USD Million (2016-2021)
  • Table 122. Mexico Kyphoplasty, by Application USD Million (2016-2021)
  • Table 123. Mexico Kyphoplasty, by End-users USD Million (2016-2021)
  • Table 124. Mexico Kyphoplasty, by Indication USD Million (2016-2021)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Kyphoplasty: by Type(USD Million)
  • Table 136. Kyphoplasty Balloon Catheters , by Region USD Million (2022-2027)
  • Table 137. Kyphoplasty Bone Access Devices , by Region USD Million (2022-2027)
  • Table 138. Kyphoplasty Cement Application Products , by Region USD Million (2022-2027)
  • Table 139. Kyphoplasty Bone Cement , by Region USD Million (2022-2027)
  • Table 140. Kyphoplasty Cement Mixing Systems , by Region USD Million (2022-2027)
  • Table 141. Kyphoplasty Instruments , by Region USD Million (2022-2027)
  • Table 142. Kyphoplasty: by Application(USD Million)
  • Table 143. Kyphoplasty Vertebral Alignment Restoration , by Region USD Million (2022-2027)
  • Table 144. Kyphoplasty Spinal Fractures , by Region USD Million (2022-2027)
  • Table 145. Kyphoplasty Kyphosis , by Region USD Million (2022-2027)
  • Table 146. Kyphoplasty: by End-users(USD Million)
  • Table 147. Kyphoplasty Hospitals , by Region USD Million (2022-2027)
  • Table 148. Kyphoplasty Clinics , by Region USD Million (2022-2027)
  • Table 149. Kyphoplasty Ambulatory Surgical Devices , by Region USD Million (2022-2027)
  • Table 150. Kyphoplasty Others , by Region USD Million (2022-2027)
  • Table 151. Kyphoplasty: by Indication(USD Million)
  • Table 152. Kyphoplasty Osteoporosis , by Region USD Million (2022-2027)
  • Table 153. Kyphoplasty Others , by Region USD Million (2022-2027)
  • Table 154. South America Kyphoplasty, by Country USD Million (2022-2027)
  • Table 155. South America Kyphoplasty, by Type USD Million (2022-2027)
  • Table 156. South America Kyphoplasty, by Application USD Million (2022-2027)
  • Table 157. South America Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 158. South America Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 159. Brazil Kyphoplasty, by Type USD Million (2022-2027)
  • Table 160. Brazil Kyphoplasty, by Application USD Million (2022-2027)
  • Table 161. Brazil Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 162. Brazil Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 163. Argentina Kyphoplasty, by Type USD Million (2022-2027)
  • Table 164. Argentina Kyphoplasty, by Application USD Million (2022-2027)
  • Table 165. Argentina Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 166. Argentina Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 167. Rest of South America Kyphoplasty, by Type USD Million (2022-2027)
  • Table 168. Rest of South America Kyphoplasty, by Application USD Million (2022-2027)
  • Table 169. Rest of South America Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 170. Rest of South America Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 171. Asia Pacific Kyphoplasty, by Country USD Million (2022-2027)
  • Table 172. Asia Pacific Kyphoplasty, by Type USD Million (2022-2027)
  • Table 173. Asia Pacific Kyphoplasty, by Application USD Million (2022-2027)
  • Table 174. Asia Pacific Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 175. Asia Pacific Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 176. China Kyphoplasty, by Type USD Million (2022-2027)
  • Table 177. China Kyphoplasty, by Application USD Million (2022-2027)
  • Table 178. China Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 179. China Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 180. Japan Kyphoplasty, by Type USD Million (2022-2027)
  • Table 181. Japan Kyphoplasty, by Application USD Million (2022-2027)
  • Table 182. Japan Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 183. Japan Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 184. India Kyphoplasty, by Type USD Million (2022-2027)
  • Table 185. India Kyphoplasty, by Application USD Million (2022-2027)
  • Table 186. India Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 187. India Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 188. South Korea Kyphoplasty, by Type USD Million (2022-2027)
  • Table 189. South Korea Kyphoplasty, by Application USD Million (2022-2027)
  • Table 190. South Korea Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 191. South Korea Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 192. Australia Kyphoplasty, by Type USD Million (2022-2027)
  • Table 193. Australia Kyphoplasty, by Application USD Million (2022-2027)
  • Table 194. Australia Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 195. Australia Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 196. Rest of Asia-Pacific Kyphoplasty, by Type USD Million (2022-2027)
  • Table 197. Rest of Asia-Pacific Kyphoplasty, by Application USD Million (2022-2027)
  • Table 198. Rest of Asia-Pacific Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 199. Rest of Asia-Pacific Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 200. Europe Kyphoplasty, by Country USD Million (2022-2027)
  • Table 201. Europe Kyphoplasty, by Type USD Million (2022-2027)
  • Table 202. Europe Kyphoplasty, by Application USD Million (2022-2027)
  • Table 203. Europe Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 204. Europe Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 205. Germany Kyphoplasty, by Type USD Million (2022-2027)
  • Table 206. Germany Kyphoplasty, by Application USD Million (2022-2027)
  • Table 207. Germany Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 208. Germany Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 209. France Kyphoplasty, by Type USD Million (2022-2027)
  • Table 210. France Kyphoplasty, by Application USD Million (2022-2027)
  • Table 211. France Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 212. France Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 213. Italy Kyphoplasty, by Type USD Million (2022-2027)
  • Table 214. Italy Kyphoplasty, by Application USD Million (2022-2027)
  • Table 215. Italy Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 216. Italy Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 217. United Kingdom Kyphoplasty, by Type USD Million (2022-2027)
  • Table 218. United Kingdom Kyphoplasty, by Application USD Million (2022-2027)
  • Table 219. United Kingdom Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 220. United Kingdom Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 221. Netherlands Kyphoplasty, by Type USD Million (2022-2027)
  • Table 222. Netherlands Kyphoplasty, by Application USD Million (2022-2027)
  • Table 223. Netherlands Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 224. Netherlands Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 225. Rest of Europe Kyphoplasty, by Type USD Million (2022-2027)
  • Table 226. Rest of Europe Kyphoplasty, by Application USD Million (2022-2027)
  • Table 227. Rest of Europe Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 228. Rest of Europe Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 229. MEA Kyphoplasty, by Country USD Million (2022-2027)
  • Table 230. MEA Kyphoplasty, by Type USD Million (2022-2027)
  • Table 231. MEA Kyphoplasty, by Application USD Million (2022-2027)
  • Table 232. MEA Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 233. MEA Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 234. Middle East Kyphoplasty, by Type USD Million (2022-2027)
  • Table 235. Middle East Kyphoplasty, by Application USD Million (2022-2027)
  • Table 236. Middle East Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 237. Middle East Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 238. Africa Kyphoplasty, by Type USD Million (2022-2027)
  • Table 239. Africa Kyphoplasty, by Application USD Million (2022-2027)
  • Table 240. Africa Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 241. Africa Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 242. North America Kyphoplasty, by Country USD Million (2022-2027)
  • Table 243. North America Kyphoplasty, by Type USD Million (2022-2027)
  • Table 244. North America Kyphoplasty, by Application USD Million (2022-2027)
  • Table 245. North America Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 246. North America Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 247. United States Kyphoplasty, by Type USD Million (2022-2027)
  • Table 248. United States Kyphoplasty, by Application USD Million (2022-2027)
  • Table 249. United States Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 250. United States Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 251. Canada Kyphoplasty, by Type USD Million (2022-2027)
  • Table 252. Canada Kyphoplasty, by Application USD Million (2022-2027)
  • Table 253. Canada Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 254. Canada Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 255. Mexico Kyphoplasty, by Type USD Million (2022-2027)
  • Table 256. Mexico Kyphoplasty, by Application USD Million (2022-2027)
  • Table 257. Mexico Kyphoplasty, by End-users USD Million (2022-2027)
  • Table 258. Mexico Kyphoplasty, by Indication USD Million (2022-2027)
  • Table 259. Research Programs/Design for This Report
  • Table 260. Key Data Information from Secondary Sources
  • Table 261. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Kyphoplasty: by Type USD Million (2016-2021)
  • Figure 5. Global Kyphoplasty: by Application USD Million (2016-2021)
  • Figure 6. Global Kyphoplasty: by End-users USD Million (2016-2021)
  • Figure 7. Global Kyphoplasty: by Indication USD Million (2016-2021)
  • Figure 8. South America Kyphoplasty Share (%), by Country
  • Figure 9. Asia Pacific Kyphoplasty Share (%), by Country
  • Figure 10. Europe Kyphoplasty Share (%), by Country
  • Figure 11. MEA Kyphoplasty Share (%), by Country
  • Figure 12. North America Kyphoplasty Share (%), by Country
  • Figure 13. Global Kyphoplasty share by Players 2021 (%)
  • Figure 14. Global Kyphoplasty share by Players (Top 3) 2021(%)
  • Figure 15. Global Kyphoplasty share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 18. Stryker (United States) Revenue: by Geography 2021
  • Figure 19. Medtronic Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic Inc. (Ireland) Revenue: by Geography 2021
  • Figure 21. Smith & Nephew (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Smith & Nephew (United Kingdom) Revenue: by Geography 2021
  • Figure 23. MicroPort Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 24. MicroPort Scientific Corporation (China) Revenue: by Geography 2021
  • Figure 25. DePuy Synthes (United States) Revenue, Net Income and Gross profit
  • Figure 26. DePuy Synthes (United States) Revenue: by Geography 2021
  • Figure 27. IZI Medical Products (United States) Revenue, Net Income and Gross profit
  • Figure 28. IZI Medical Products (United States) Revenue: by Geography 2021
  • Figure 29. CareFusion (United States) Revenue, Net Income and Gross profit
  • Figure 30. CareFusion (United States) Revenue: by Geography 2021
  • Figure 31. Merit Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merit Medical Systems (United States) Revenue: by Geography 2021
  • Figure 33. Joimax GmbH (United States) Revenue, Net Income and Gross profit
  • Figure 34. Joimax GmbH (United States) Revenue: by Geography 2021
  • Figure 35. G21 S.r.l. (Italy) Revenue, Net Income and Gross profit
  • Figure 36. G21 S.r.l. (Italy) Revenue: by Geography 2021
  • Figure 37. Global Kyphoplasty: by Type USD Million (2022-2027)
  • Figure 38. Global Kyphoplasty: by Application USD Million (2022-2027)
  • Figure 39. Global Kyphoplasty: by End-users USD Million (2022-2027)
  • Figure 40. Global Kyphoplasty: by Indication USD Million (2022-2027)
  • Figure 41. South America Kyphoplasty Share (%), by Country
  • Figure 42. Asia Pacific Kyphoplasty Share (%), by Country
  • Figure 43. Europe Kyphoplasty Share (%), by Country
  • Figure 44. MEA Kyphoplasty Share (%), by Country
  • Figure 45. North America Kyphoplasty Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Stryker (United States)
  • Medtronic Inc. (Ireland)
  • Smith & Nephew (United Kingdom)
  • MicroPort Scientific Corporation (China)
  • DePuy Synthes (United States)
  • IZI Medical Products (United States)
  • CareFusion (United States)
  • Merit Medical Systems (United States)
  • joimax GmbH (United States)
  • G21 S.r.l. (Italy)
Additional players considered in the study are as follows:
Joline GmbH & Co. KG (Germany) , Seawon MediTech (South Korea) , Hensler Surgical Products (United States) , Others
Select User Access Type

Key Highlights of Report


Aug 2022 224 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Kyphoplasty Market Quantitative research analysis
Global Kyphoplasty Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Kyphoplasty Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Kyphoplasty market is dominated by United States Players and may generate healthy valuation by 2027.
  • Increased Prevalence of Kyphoplasty Compression Fractures
  • Increased Number of Diagnostic Centers and Hospitals
dominated the Kyphoplasty market. This is attributable to growing trend of "Rise in the Healthcare Infrastructure in Developing Regions "

Know More About Global Kyphoplasty Market Report?

Have a Query? Click Here

Other Related Reports

Salt Rooms Construction Comprehensive Study by Type (Salt Walls, Bricks & Tiles, Salt Booths & Capsules, Salt Beds & Tables, Halogenerator, Salt Binder, Salt Lamp, Others), Application (Spa and Welln...
$ 3800
Pet Animal Health Product Comprehensive Study by Type (Vaccines, Pharmaceuticals, Calcium Supplement, Others), End Users (Commercials, Household, Pet hospital, Others), Distribution Channels (Online,...
$ 3800
Papillomavirus Hpv Testing Comprehensive Study by Type (HPV Testing, Pap Test), Application (Cervical Cancer Screening, Vaginal Cancer Screening, Molecular Diagnostics, Research Use), End User (Labo...
$ 3800
Paediatric Epilepsy Therapeutics Comprehensive Study by Application (Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers), Disease Type (Benign Rolandic Epilepsy, Childhood ...
$ 3800
European Online Pharmacy (E-Pharma) Comprehensive Study by Type (Prescription Drugs, Over-the-counter (OTC) Drugs), Application (Skin Care, Dental, Vitamins, Weight Loss, Others), Components (Web-Bas...
$ 3800
Emergency Ambulance Vehicle Comprehensive Study by Application (Hospitals, Emergency Center, Others), Ambulance Equipment (Advanced Life Support Ambulance Services (ALS), Basic Life Support Ambulance...
$ 3800